KRTAP9-3 inhibitors refer to a class of chemical compounds that target the Keratin-Associated Protein 9-3 (KRTAP9-3) gene or its protein product. KRTAP proteins are a large family of structural proteins that contribute to the formation and regulation of keratin fibers, which are the fundamental components of hair, nails, and the outer layer of skin. KRTAP9-3 specifically is one of these proteins, and its expression is linked to the organization and physical properties of keratinized tissues. Inhibitors of KRTAP9-3 are designed to interfere with the normal function or expression of this protein, potentially by binding to active sites on the protein or influencing the transcription or translation processes involved in its production.
From a biochemical perspective, KRTAP9-3 inhibitors may function through a variety of mechanisms, including the disruption of protein-protein interactions within keratin fibers or the modification of post-translational processes that affect keratin stability. These inhibitors could potentially act by altering the conformation of the KRTAP9-3 protein, thereby hindering its ability to integrate into keratin structures. Alternatively, they may block signal transduction pathways responsible for the regulation of KRTAP9-3 gene expression, effectively reducing its production. Understanding the molecular structure and functional dynamics of these inhibitors is critical for advancing our knowledge of keratin biology, and their study can offer insights into the complex processes that govern cellular differentiation, tissue integrity, and the overall biophysical properties of keratin-rich structures.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $38.00 $58.00 $102.00 $202.00 | 8 | |
HSP90 inhibitor that can destabilize client proteins, potentially affecting KRTAP9-3 stability. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $127.00 $572.00 $4090.00 $20104.00 | 20 | |
Compound known to disrupt cytoskeletal proteins, which could affect KRTAP9-3's interaction with keratins. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Protein synthesis inhibitor that can reduce overall protein levels, potentially reducing KRTAP9-3 expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
Proteasome inhibitor that can increase protein levels, potentially affecting KRTAP9-3 turnover. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Histone deacetylase inhibitor that can alter gene expression, potentially affecting KRTAP9-3 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor that can affect gene expression, potentially influencing KRTAP9-3. | ||||||
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $67.00 $306.00 | 2 | |
Cyclin-dependent kinase inhibitor that can disrupt cell cycle, potentially affecting KRTAP9-3 levels. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
SERCA pump inhibitor that can induce ER stress, potentially impacting KRTAP9-3 folding or stability. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Signaling molecule that can regulate gene expression, potentially affecting KRTAP9-3 levels. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Lysosomotropic agent that can raise lysosomal pH, potentially affecting KRTAP9-3 degradation. | ||||||